Can sh-Polypeptide-7 Be Combined with Other Treatments Like Minoxidil or Microneedling for Better Results?

Comparing a newer cosmetic ingredient such as sh-Polypeptide-7 with established treatments like minoxidil and microneedling means separating what has been clinically demonstrated from what is promotional language. Minoxidil and microneedling are supported by controlled human studies. sh-Polypeptide-7 exists primarily within the cosmetic industry without comparable published research. The question worth answering is therefore whether combination use is grounded in evidence or is simply speculation.

What Minoxidil and Microneedling Actually Do

Minoxidil is a topical medication approved by the U.S. Food and Drug Administration for androgenetic alopecia. It is described as widening blood vessels in the scalp, increasing oxygen and nutrient delivery to hair follicles, and extending the anagen phase, which is the active growth phase of the hair cycle. That allows hair to grow thicker and remain on the scalp longer before shedding. Microneedling involves creating microscopic punctures in the scalp using fine needles. These small injuries stimulate the body's natural healing response, increasing blood flow and releasing growth factors that support tissue repair. The micro-channels also allow topical products such as minoxidil to penetrate deeper into the skin, which researchers propose as one reason the combination performs better.

A 2023 meta-analysis of randomised trials found that microneedling plus minoxidil increased total hair count more than minoxidil alone, while the difference in hair thickness (diameter) was not statistically significant. Those studies are mostly short-term and involve relatively small participant groups, which limits how broadly the results can be applied.

What sh-Polypeptide-7 Is and Why Evidence Is Scarce

sh-Polypeptide-7 is the INCI (cosmetic-ingredient) name for a laboratory-made, recombinant form of human somatotropin — the hormone better known as human growth hormone. It is worth noting that it is often confused with Epidermal Growth Factor, which is a different molecule with its own INCI name, sh-Oligopeptide-1. In theory, signalling peptides of this kind can influence cell pathways related to growth and repair. In practice, sh-Polypeptide-7 is sold as a cosmetic ingredient rather than a medical treatment. The critical issue is that there appear to be no peer-reviewed human studies published in recognised scientific journals that directly evaluate sh-Polypeptide-7 for hair regrowth. Most information about it comes from ingredient databases and manufacturer descriptions rather than controlled experiments. Without that research, claims of hair stimulation remain unverified, and its long-term safety on the scalp has not been characterised.

Can sh-Polypeptide-7 Improve Results When Combined With Proven Treatments?

No published study was found showing that combining sh-Polypeptide-7 with minoxidil or microneedling improves outcomes. Microneedling enhances absorption of topical substances in general, but that does not mean an unproven ingredient becomes effective simply by reaching deeper skin layers.

The evidence supports the statement that minoxidil combined with microneedling outperforms minoxidil alone. What the evidence does not address is whether adding sh-Polypeptide-7 contributes anything to that improvement. At present, any assumption of benefit is hypothetical.

There is also a practical caution that is easy to miss. Microneedling drives whatever is on the scalp past the skin barrier and into the dermis. An ingredient that has not been studied for topical use — and a recombinant hormone-derived peptide is exactly that — is being delivered under very different conditions from ordinary application, and nothing published describes what happens then. Ask a doctor before applying any product to microneedled skin.

Understanding the Technical Limitations of Existing Studies

Many microneedling and minoxidil studies follow participants for only twelve to twenty-four weeks, even though hair growth cycles run for years. Sample sizes are often under one hundred participants, which increases statistical variability. Methods of measuring improvement also differ between studies — visual scoring, hair counts, photographic comparison — which introduces subjectivity.

For sh-Polypeptide-7, the limitation is more fundamental: no clinical trials appear to exist. Without controlled human research, there is no basis on which to judge effectiveness, concentration, long-term safety, or interaction with established treatments. For anyone considering combining treatments, the published evidence supports microneedling with minoxidil. Adding sh-Polypeptide-7 has not been shown to be harmful, but neither has it been shown to help, and "not shown to be harmful" is not the same as "shown to be safe" for an ingredient with no published scalp studies. Untested cosmetic peptides are worth treating cautiously, particularly where treatments with published evidence already exist.

Conclusion: Evidence Over Assumptions

Multiple clinical trials and a systematic review report that minoxidil and microneedling together give better results than minoxidil alone. sh-Polypeptide-7, by contrast, lacks peer-reviewed human research supporting a role in hair growth. There is currently no published basis for the claim that combining sh-Polypeptide-7 with established treatments leads to better outcomes, and until controlled clinical studies exist its effectiveness remains speculative.

Talk to a doctor, dermatologist or pharmacist before starting, stopping or combining hair-loss treatments — particularly before microneedling the scalp, before applying any product into microneedled skin, and before using a hormone-derived ingredient if you are pregnant, breastfeeding, or have an endocrine condition.

References

Dhurat, R., Sukesh, M., Avhad, G., Dandale, A., Pal, A., & Pund, P. (2013). A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: A pilot study. International Journal of Trichology, 5(1), 6–11. https://pubmed.ncbi.nlm.nih.gov/23960389/

Zhang, Y., Sheng, Y., Zeng, Y., Hu, R., Zhao, J., & Wang, W. (2022). Randomized trial of microneedling combined with 2% minoxidil topical solution for the treatment of female pattern hair loss in a Chinese population. Journal of Cosmetic Dermatology, 21(12), 6985–6991. https://pubmed.ncbi.nlm.nih.gov/36214061/

Abdi, P., Awad, C., Anthony, M. R., Farkouh, C., Kenny, B., Maibach, H. I., & Ogunyemi, B. (2023). Efficacy and safety of combinational therapy using topical minoxidil and microneedling for the treatment of androgenetic alopecia: A systematic review and meta-analysis. Archives of Dermatological Research, 315(10), 2775–2785. https://pubmed.ncbi.nlm.nih.gov/37665358/